NASDAQ: SLN
Silence Therapeutics PLC Stock Ownership - Who owns Silence Therapeutics?

Insider buying vs selling

Have Silence Therapeutics PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SLN insiders and whales buy or sell their stock.

SLN Shareholders

What type of owners hold Silence Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Siren LLC2.05%2,911,438$12.96MInstitution
Nantahala Capital Management LLC1.09%1,542,427$6.86MInstitution
Vivo Capital LLC0.78%1,105,454$4.92MInstitution
Morgan Stanley0.23%324,630$1.44MInstitution
Sg Americas Securities LLC0.18%256,340$1.14MInstitution
Ubs Group Ag0.15%207,513$923.43kInstitution
M28 Capital Management LP0.13%185,100$823.70kInstitution
Bank Of Montreal0.11%160,474$714.11kInstitution
Marshall Wace LLP0.11%155,680$692.78kInstitution
Blackrock Inc0.05%73,153$325.53kInstitution

1 of 3

SLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLN4.99%0.09%
NVCT14.88%42.17%Net Buying
PLX7.07%92.93%Net BuyingNet Buying
FENC2.59%97.41%Net SellingNet Selling
MDWD28.80%0.00%

Silence Therapeutics Stock Ownership FAQ

Who owns Silence Therapeutics?

Silence Therapeutics (NASDAQ: SLN) is owned by 4.99% institutional shareholders, 0.09% Silence Therapeutics insiders, and 94.92% retail investors. Iain Ross is the largest individual Silence Therapeutics shareholder, owning 39,942.00 shares representing 0.03% of the company. Iain Ross's Silence Therapeutics shares are currently valued at $200.11k.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.